DWHP invests in CEFALY Technology SPRL
DW Healthcare Partners (DWHP), a healthcare-focused private equity firm, has made a majority investment in CEFALY Technology SPRL (CEFALY), a global manufacturer and marketer of neuro-modulating medical devices for the prevention and treatment of migraines. CEFALY is the first investment in DW Healthcare Partners V, the firm’s recently closed, USD610